Study With Two Coenzyme Q10 Products
- Conditions
- Coenzyme Q Deficiency
- Registration Number
- NCT06736366
- Lead Sponsor
- University of Primorska
- Brief Summary
The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products
- Detailed Description
The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products will include 35 subjects who will test two different coenzyme Q10 products. Plasma concentration of coenzyme Q10 will be measured.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 35
- subject informed consent form
- aged between 50 and 65 years old
- body mass for women 70± 5 kg and for men 85± 5 kg
- non-smoking
- healthy, without cardio-vascular diseases, diabetes, neurodegenerative diseases
- absence of any prescribed medication during the study
- willing to avoid a consumption of any food supplements at least 2 weeks before and during the study
- cardio-vascular diseases, diabetes, neurodegenerative diseases, gastrointestinal disorders, pregnancy, breast-feeding
- intake of any food supplements within two week of the beginning of the study
- drug or alcohol abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Plasma levels of Coenzyme Q10 Forthy-eight hours after consumption Plasma levels of Coenzyme Q10 will be measured by high-performance liquid chromatography (HPLC) with electrochemical detection and a post-analytical reducing column, using a Nanospace HPLC apparatus.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Primorska, Faculty of Health Sciences
🇸🇮Izola, Slovenia